Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic estrogen in recurrent postpartum affective disorder

D A Sichel1, L S Cohen, L M Robertson

  • 1Clinical Psychopharmacology Unit, Massachusets General Hospital, Boston 02114, USA.

Biological Psychiatry
|December 15, 1995
PubMed
Summary

High-dose oral estrogen given immediately after delivery significantly reduced postpartum mood disorder relapse in at-risk women. This estrogen therapy may prevent postpartum psychosis and depression by stabilizing hormone levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 100-Year Review: Lactating dairy cattle housing management.

Journal of dairy science·2017
Same author

Efficacy of anthelmintic treatment in captive-reared black stilts (Himantopus novaezelandiae) released to the wild.

New Zealand veterinary journal·2015
Same author

Behavioral inhibition in childhood predicts smaller hippocampal volume in adolescent offspring of parents with panic disorder.

Translational psychiatry·2015
Same author

Personality and bipolar disorder: dissecting state and trait associations between mood and personality.

Psychological medicine·2010
Same author

Evidence of multiple retrotransposons in two litopenaeid species.

Animal genetics·2008
Same author

Odysseus syndrome: nihilism by proxy.

International journal of geriatric psychiatry·2005

Area of Science:

  • Reproductive Psychiatry
  • Neuroendocrinology
  • Perinatal Mental Health

Background:

  • Postpartum affective disorders, including psychosis and major depression, affect a significant number of women.
  • Women with a history of puerperal illness are at high risk for recurrence after subsequent deliveries.

Purpose of the Study:

  • To investigate the efficacy of high-dose oral estrogen as a prophylactic treatment for preventing postpartum affective disorders in at-risk women.
  • To explore the potential mechanism of estrogen's effect on mood regulation in the postpartum period.

Main Methods:

  • A consecutive series of 11 women with histories of puerperal psychosis or major depression received high-dose oral estrogen immediately postpartum.
  • Women were monitored for affective relapse over a 1-year follow-up period.

Related Experiment Videos

  • No participants had histories of nonpuerperal affective disorder and were well during pregnancy and at delivery.

    • Main Results:

    • Only one woman (9%) experienced a relapse of postpartum affective disorder during the 1-year follow-up.
    • This relapse rate is substantially lower than the expected 35-60% without prophylactic treatment.
    • No participants required psychotropic medication during the follow-up period.

    Conclusions:

    • High-dose oral estrogen administered immediately after delivery appears to be a highly effective prophylaxis against puerperal affective disorders in at-risk women.
    • Estrogen therapy may mitigate the effects of rapid postpartum estrogen withdrawal on neuroreceptors, potentially preventing mood disorder onset.
    • This approach offers a promising non-psychotropic strategy for managing postpartum mood disorder risk.